Making good decisions in the drug discovery process requires software to effectively manage the size and complexity of multiparametric datasets. Companies that most quickly and accurately identify key drug discovery parameters will win the race to identify the most appropriate targets and develop medicines to affect them. This whitepaper takes a look at the requirements for High Throughput Screening, High Content Screening and Surface Plasmon Resonance. It makes suggestions for how best to streamline and make these processes more flexible and repeatable.
Like what you're reading?
To view the full content, please fill out this form: